Mankind Pharma

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue2,3192,4262,0802,4982,636
Expenses1,7441,8491,5681,9211,865
EBITDA656.25670.34599.02667.03857.79
EBIT579.24580.61516.77583.63772.37
Profit Before Tax601.02576.35536.32606.61802.44
Net Profit472.88487.07454.17513.49634.43
Financial Ratios
Operating Profit Margin30.19%28.42%31.18%28.97%35.17%
Net Profit Margin19.77%20.65%21.57%20.15%23.81%
Earning Per Share (Diluted)11.7912.1411.3212.8015.81
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2025 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.6.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ